Global Hemoperfusion Production Market Is Valued At USD 323.16 Million In 2017 And Is Expected To Reach USD 772.61 Million By The End Of 2024
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
Hemoperfusion production has relatively high technology barrier and is technology intensive industry. The main market players are Baxter (Gambro), Asahi, Kaneka, Jafron Biomedical, etc. The global production of hemoperfusion will increase to 3841.5 K Units in 2018 from 1597.9 K Units in 2013 with CAGR of 19.31%.
In 2017, China consumption volume reached 1907.5 K Units, due to the bigger demand of downstream applications and the larger population and policy support; while Europe consumed 725.4 K Units and Japan consumed 362.7 K Units.
Hemoperfusion mainly has two types, which include activated carbon adsorption hemoperfusion and resin adsorption hemoperfusion. With medical effect of hemoperfusion, the downstream application industries will need more hemoperfusion products.
The major raw materials for hemoperfusion are polypropylene, polycarbonate, membrane materials, activated carbon, etc. Fluctuations in the price of the upstream product will impact on the production cost of hemoperfusion, and then impact the price of hemoperfusion. The production cost of hemoperfusion is also an important factor which could impact the price of hemoperfusion.
We tend to believe this industry is a rising industry, and the consumption increasing degree will show an increasing growth curve. And the price presents fluctuation according to the economy development status and international competition. Also, there will be fluctuation in gross margin.